Effect of CRP and SAA Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections

Recruiting N/A Interventional Study
Antibiotic Prescribing for Acute Respiratory-tract Infections
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
19,424 (estimated)
Sponsor
Huazhong University of Science and Technology · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study was a practical, cluster-randomized controlled trial to evaluate the impact of CRP and SAA point-of-care testing (CRP\&SAA POCT) on antibiotic prescribing in patients with acute respiratory-tract infections (ARI) at primary care facilities in rural China.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Eligibility criteria for clusters Village clinics with an annual outpatient volume exceeding 2000, an average of 10 or more patients per week presenting with ARIs, and licensed prescribers are considered eligible for selection for the intervention. Annual outpatient prescriptions and average weekly …
Contacts

Xiaoxv Yin, PhD

+86 13871187781

yxx@hust.edu.cn

CONTACT

Minzhi Xu, PhD

+86 18737357795

619581384@qq.com

CONTACT